Volume 5, Number 1, 59-61, DOI: 10.1007/BF00852847

Published in partnership with the

Logo

International Pediatric Nephrology Association

Sister chromatid exchange analysis in monitoring chlorambucil therapy in primary nephrotic syndrome of childhood

A. Y. Elzouki, K. Al-Nassar, M. Al-Ali, G. Malik, F. Elsharie and O. P. Jaiswal

View Related Documents

Abstract

Sister chromatid exchange (SCE) analysis is the most sensitive method for assessing chromosome damage induced by chemical mutagens. We report the SCE of peripheral blood lymphocytes in children with primary nephrotic syndrome (NS) treated with chlorambucil. Group I consisted of 20 normal children, group 2 of 14 children with primary NS who had never received a cytotoxic drug and group III of 7 children with primary NS who had received chlorambucil, which was discontinued 6–36 months prior to the study. Group IV consisted of 4 nephrotic children who were receiving chlorambucil therapy during the study. There was no significant increase in SCE in group III compared with group I or group II (PGt0.05). A significant rise in SCE (P<0.05) was="" seen="" in="" all="" patients="" in="" group="">

Key words  Chlorambucil - Nephrotic syndrome - Malignancy - Leukaemia

Fulltext Preview

Image of the first page of the fulltext document